Oncologic outcomes of partial versus radical nephrectomy for unilateral Wilms Tumor

被引:36
作者
Cost, Nicholas G. [1 ,2 ]
Lubahn, Jessica D.
Granberg, Candace F.
Schlomer, Bruce J.
Wickiser, Jonathan E. [3 ]
Rakheja, Dinesh [4 ]
Gargollo, Patricio C.
Leonard, David [5 ]
Raj, Ganesh V. [2 ]
Baker, Linda A.
Margulis, Vitaly [2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Urol, Div Pediat Urol, Childrens Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Div Urol Oncol, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Div Pediat Hematol Oncol, Childrens Med Ctr Dallas, Dallas, TX 75390 USA
[4] Univ Texas SW Med Ctr Dallas, Dept Pathol, Childrens Med Ctr Dallas, Dallas, TX 75390 USA
[5] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA
关键词
partial nephrectomy; nephron sparing; wilms tumor; nephroblastoma; pediatric renal tumor; NEPHRON-SPARING SURGERY; PREOPERATIVE CHEMOTHERAPY; CHILDREN; CANCER; REDUCTION; GROWTH; RISK;
D O I
10.1002/pbc.23240
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Radical nephrectomy (RN) is the recommended surgical management as part of multi-modality therapy for unilateral Wilms tumor (UWT). Based on recent data demonstrating that renal preserving surgery decreases the likelihood of chronic renal disease and associated co-morbidities, we analyzed oncologic outcomes of patients after partial nephrectomy (PN) for UWT. Methods. We identified all published cases of PN for UWT. Cases of elective PN for UWT were analyzed for tumor stage, presence, timing and location of disease recurrence, and overall survival (OS). Eighty-two patients had adequate data for analysis. For comparison, these endpoints were collected on consecutive children undergoing RN for UWT from 1985 to 2010 at our institution. Results. Of the 82 PN patients, tumor stage was: I-64, II-10, III-6, IV-2. Of the 121 RN patients, the staging was: I-24, II-45, III-29, IV-23. In the PN group, at a median of 48 months (3-372), the recurrence-free survival (RFS), local RFS and OS were 89.1%, 92.7%, and 95.1%, respectively. In the RN group, at a median of 69 months (0-214), the RFS, local RFS, and OS were 83.1%, 95.0%, and 95.0%, respectively. After controlling for stage, there were no statistically significant differences in the above oncologic outcomes between the groups. Conclusion. Based on reported data, the oncologic outcomes of PN for UWT in selected patients do not appear to differ from those of RN. PN for appropriately selected patients with UWT should be studied in prospective, co-operative group trials. Pediatr Blood Cancer 2012; 58: 898-904. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:898 / 904
页数:7
相关论文
共 48 条
[1]  
Acosta D, 2001, Cir Pediatr, V14, P139
[2]  
Apoznanski W, 2008, ADV CLIN EXP MED, V17, P77
[3]  
BISHOP HC, 1985, MED PEDIATR ONCOL, V13, P37
[4]   Outcome of children with cystic partially differentiated nephroblastoma treated with or without chemotherapy [J].
Blakely, ML ;
Shamberger, RC ;
Norkool, P ;
Beckwith, JB ;
Green, DM ;
Ritchey, ML .
JOURNAL OF PEDIATRIC SURGERY, 2003, 38 (06) :897-900
[5]  
Breslow NE, 2000, CANCER RES, V60, P4030
[6]   Early and Late Mortality After Diagnosis of Wilms Tumor [J].
Cotton, Cecilia A. ;
Peterson, Susan ;
Norkool, Patricia A. ;
Takashima, Janice ;
Grigoriev, Yevgeny ;
Breslow, Norman E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1304-1309
[7]   Compensatory renal growth in children with unilateral renal tumor treated by nephron-sparing surgery or nephrectomy [J].
Cozzi, F. ;
Zani, A. ;
Schiavetti, A. ;
Morini, F. ;
deGaetano, V. ;
Matrunola, M. ;
Cozzi, D. A. .
EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2007, 17 (06) :382-386
[8]   Renal function adaptation in children with unilateral renal tumors treated with nephron sparing surgery or nephrectomy [J].
Cozzi, F ;
Schiavetti, A ;
Morini, F ;
Zani, A ;
Gambino, M ;
Donfrancesco, C ;
Cozzi, DA .
JOURNAL OF UROLOGY, 2005, 174 (04) :1404-1408
[9]  
Dall'Igna P, 1998, MED PEDIATR ONCOL, V31, P358
[10]  
DANGIO GJ, 1989, CANCER-AM CANCER SOC, V64, P349, DOI 10.1002/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO